Intimation for the 47th Annual General Meeting & Annual Report for the FY 2024-25
SHIVALIK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivalik Rasayan has announced its 47th AGM to be held on September 27, 2025 via video conferencing, along with the FY 2024-25 Annual Report. Revenue grew sharply to Rs. 149.22 Crores from Rs. 93.67 Crores in the prior year, EBITDA rose to Rs. 28.40 Crores from Rs. 18.72 Crores, and PAT climbed to Rs. 13.86 Crores from Rs. 8.64 Crores. Key milestones included US FDA approval for the new API plant in October 2024 and the commissioning of the greenfield Dahej III facility in September 2024, which lifted Dimethoate Technical capacity by 250%. A 10% dividend (Rs. 0.50 per share) has been proposed, with a record date of September 20, 2025 and payment on or after October 15, 2025. The company also disclosed a healthy pipeline: 34 agrochemical products awaiting CIB&RC clearance, 7 CDMO products for European markets, and a partnership with a US firm to develop 5 complex molecules.
Strong revenue and earnings growth, along with US FDA approval and a visible product pipeline, point to a positive growth trajectory for the stock. Shareholders benefit from a 10% dividend, while AGM resolutions seek re-appointment of directors and appointment of a new secretarial auditor.